Treatment Overview Cancer risk stratification in Korea is a comprehensive evaluation to categorize patients based on their likelihood of developing or progressing with prostate cancer.

Treatment Overview Prostate volume measurement is a diagnostic procedure that evaluates the size of the prostate gland, which is important for assessing conditions such as

Treatment Overview Hormone level assessment for screening in Korea evaluates key male hormones, primarily testosterone, dihydrotestosterone (DHT), luteinizing hormone (LH), and follicle-stimulating hormone (FSH), to

Treatment Overview Screening for urinary symptoms in Korea involves a comprehensive evaluation of men experiencing lower urinary tract symptoms (LUTS), such as frequent urination, weak

Treatment Overview Active Surveillance Evaluation is a comprehensive monitoring program for men diagnosed with low-risk or early-stage prostate cancer. Instead of immediate treatment, patients are

Treatment Overview Repeat PSA Monitoring is a follow-up blood test strategy used to track prostate-specific antigen (PSA) levels over time. This method helps assess prostate

Treatment Overview High-Risk Patient Screening for prostate cancer in Korea is a comprehensive diagnostic approach for men with elevated risk factors, such as family history,

Treatment Overview Targeted Biopsy Planning is a precision approach to diagnosing prostate cancer. It involves using advanced imaging techniques, such as multiparametric MRI (mpMRI) or

Treatment Overview Early Detection Screening for prostate cancer in Korea involves a combination of tests and examinations aimed at identifying prostate abnormalities at the earliest

Treatment Overview The 4Kscore Test is an advanced blood test that evaluates a man’s risk of aggressive prostate cancer. It measures four prostate-specific kallikrein protein